Understanding Patient Preference on Colorectal Cancer Screening Options-PSU

Description

There are significant barriers to colorectal cancer screening within underserved populations due to the cost, accessibility, and acceptability of screening methods. Patient-friendly approaches that minimize stress and discomfort for the patient are needed to enhance screening compliance and achieve an early diagnosis. The primary aim of this study is to examine whether the availability of a blood-based screening option, which can be done at the point of service and is familiar to patients, will improve patient compliance to recommended CRC screening

Conditions

Colo-rectal Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

There are significant barriers to colorectal cancer screening within underserved populations due to the cost, accessibility, and acceptability of screening methods. Patient-friendly approaches that minimize stress and discomfort for the patient are needed to enhance screening compliance and achieve an early diagnosis. The primary aim of this study is to examine whether the availability of a blood-based screening option, which can be done at the point of service and is familiar to patients, will improve patient compliance to recommended CRC screening

Understanding Patient Preference on Colorectal Cancer Screening Options

Understanding Patient Preference on Colorectal Cancer Screening Options-PSU

Condition
Colo-rectal Cancer
Intervention / Treatment

-

Contacts and Locations

Hershey

Penn State College of Medicine, Hershey, Pennsylvania, United States, 17033

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Between 45-75 years of age
  • 2. Language Proficiency: participants must be fluent in English or Spanish
  • 3. Have an average risk for colorectal cancer
  • 4. Be a patient at one of our partner FQHCs
  • 5. Received a screening order (either using a stool-based test or colonoscopy) six months ago and failed or refused to complete the screening test
  • 6. Able and willing to provide a blood sample per protocol
  • 1. Family history
  • * One first-degree relative diagnosed with CRC or advanced adenoma at age \<60 years
  • * Two first-degree relatives diagnosed with CRC or advanced adenoma at any age
  • * Known hereditary gastrointestinal cancer syndromes, such as Lynch Syndrome or Familial Adenomatous and Polyposis (FAP)
  • 2. Personal History
  • * Participants who do not speak either Spanish or English
  • * History of CRC or adenoma
  • * History of cancers
  • * History of inflammatory bowel disease, including chronic ulcerative colitis and Crohn's disease
  • * Have a recorded up to date CRC screening
  • * Blood product transfusion in the past 120 days
  • * A medical condition which, in the opinion of the patient's health provider, should preclude enrollment in the study

Ages Eligible for Study

45 Years to 75 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Milton S. Hershey Medical Center,

Karen E. Kim, MD, PRINCIPAL_INVESTIGATOR, Penn State College of Medicine

Study Record Dates

2026-12-31